PRTK — Paratek Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00
HealthcareAdventurousSmall Cap
- $127.83m
- $343.47m
- $160.27m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17.1 | 16.5 | 46.9 | 130 | 160 |
Cost of Revenue | |||||
Gross Profit | — | 13.1 | 38.3 | 109 | 137 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 121 | 132 | 125 | 171 | 206 |
Operating Profit | -104 | -116 | -77.9 | -41.1 | -46.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -112 | -128 | -96.5 | -58.5 | -63.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -112 | -129 | -96.5 | -59.1 | -63.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -112 | -129 | -96.5 | -59.1 | -63.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -112 | -129 | -96.5 | -59.1 | -63.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.56 | -3.93 | -2.13 | -1.22 | -1.17 |